688029 南微医学
已收盘 12-15 15:00:00
资讯
新帖
简况
南微医学（688029）披露持股5%以上股东减持股份结果公告，12月08日股价上涨0.34%
证券之星 · 12-08
南微医学（688029）披露持股5%以上股东减持股份结果公告，12月08日股价上涨0.34%
每周股票复盘：南微医学（688029）本周现超7000万大宗交易
证券之星 · 11-16
每周股票复盘：南微医学（688029）本周现超7000万大宗交易
11月14日南微医学现5806.94万元大宗交易
证券之星 · 11-14
11月14日南微医学现5806.94万元大宗交易
南微医学（688029）披露取消监事会并修订公司章程议案获通过，11月12日股价下跌0.31%
证券之星 · 11-12
南微医学（688029）披露取消监事会并修订公司章程议案获通过，11月12日股价下跌0.31%
11月11日南微医学现1292.56万元大宗交易
证券之星 · 11-11
11月11日南微医学现1292.56万元大宗交易
每周股票复盘：南微医学（688029）拟取消监事会改由董事会审计委员会履职
证券之星 · 11-09
每周股票复盘：南微医学（688029）拟取消监事会改由董事会审计委员会履职
南微医学（688029）披露拟取消监事会并修订多项治理制度，11月06日股价上涨0.83%
证券之星 · 11-06
南微医学（688029）披露拟取消监事会并修订多项治理制度，11月06日股价上涨0.83%
南微医学（688029）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 10-29
南微医学（688029）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
南微医学(688029)9月30日股东户数1.25万户，较上期增加1.38%
证券之星 · 10-28
南微医学(688029)9月30日股东户数1.25万户，较上期增加1.38%
南微医学最新公告：前三季度净利润同比增长12.90%
证券之星 · 10-27
南微医学最新公告：前三季度净利润同比增长12.90%
每周股票复盘：南微医学（688029）完成3002万元股份回购
证券之星 · 10-26
每周股票复盘：南微医学（688029）完成3002万元股份回购
南微医学（688029）披露股份回购实施结果，10月22日股价下跌0.81%
证券之星 · 10-22
南微医学（688029）披露股份回购实施结果，10月22日股价下跌0.81%
Sapura Industrial表示子公司与Funa Micro Technology Pte签署合资协议
投资观察 · 10-14
Sapura Industrial表示子公司与Funa Micro Technology Pte签署合资协议
每周股票复盘：南微医学（688029）回购进展披露，已支付约960万元
证券之星 · 10-12
每周股票复盘：南微医学（688029）回购进展披露，已支付约960万元
股市必读：9月30日南微医学发生2笔大宗交易 成交金额1505.26万元
证券之星 · 10-09
股市必读：9月30日南微医学发生2笔大宗交易 成交金额1505.26万元
南微医学涨7.52%，国金证券一个月前给出“买入”评级
证券之星 · 09-30
南微医学涨7.52%，国金证券一个月前给出“买入”评级
南微医学（688029）披露2025年半年度权益分派实施后调整回购价格上限，9月29日股价下跌0.99%
证券之星 · 09-29
南微医学（688029）披露2025年半年度权益分派实施后调整回购价格上限，9月29日股价下跌0.99%
每周股票复盘：XD南微医（688029）南微医学拟每股派0.5元现金红利
证券之星 · 09-28
每周股票复盘：XD南微医（688029）南微医学拟每股派0.5元现金红利
南微医学（688029）披露2025年半年度权益分派实施公告，9月22日股价上涨0.37%
证券之星 · 09-22
南微医学（688029）披露2025年半年度权益分派实施公告，9月22日股价上涨0.37%
中国银河：给予南微医学买入评级，目标价134.67元
证券之星 · 09-07
中国银河：给予南微医学买入评级，目标价134.67元
暂无数据
公司概况
公司名称：
南微医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-07-22
主营业务：
南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜诊疗器械、微波/射频消融设备及耗材、一次性内镜。
发行价格：
52.45
{"stockData":{"symbol":"688029","market":"SH","secType":"STK","nameCN":"南微医学","latestPrice":77.11,"timestamp":1765782000000,"preClose":77.98,"halted":0,"volume":1838845,"delay":0,"changeRate":-0.0112,"floatShares":188000000,"shares":188000000,"eps":3.2548,"marketStatus":"已收盘","change":-0.87,"latestTime":"12-15 15:00:00","open":77.88,"high":79.5,"low":77.07,"amount":144000000,"amplitude":0.0312,"askPrice":77.26,"askSize":8,"bidPrice":77.11,"bidSize":31,"shortable":0,"etf":0,"ttmEps":3.2548,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":77.98,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":85.78,"lowLimit":70.18,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":187847422,"isCdr":false,"pbRate":3.56,"roa":"--","peRate":23.691164,"roe":"12.75%","epsLYR":2.95,"committee":0.283951,"marketValue":14485000000,"turnoverRate":0.0098,"status":1,"afterMarket":{"amount":0,"volume":0,"close":77.11,"buyVolume":0,"sellVolume":0,"time":1765784037768,"indexStatus":"已收盘 12-15 15:30:00","preClose":77.98},"floatMarketCap":14485000000},"requestUrl":"/m/hq/s/688029/tweets","defaultTab":"tweets","newsList":[{"id":"2589339341","title":"南微医学（688029）披露持股5%以上股东减持股份结果公告，12月08日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339341?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:52","pubTimestamp":1765187548,"startTime":"0","endTime":"0","summary":"公司近日发布《南微医学科技股份有限公司持股5%以上股东减持股份结果公告》。公告显示，本次减持计划实施前，中科招商持有南微医学科技股份有限公司股份41,752,818股，占公司总股本的22.2270%。2025年8月18日，公司披露股东中科招商拟减持不超过3,756,948股，不超过公司总股本的2%。截至2025年12月5日，减持计划期限届满，中科招商通过集中竞价交易方式合计减持62,000股，减持比例0.03%，未通过大宗交易方式减持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2583223651","title":"每周股票复盘：南微医学（688029）本周现超7000万大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2583223651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583223651?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:56","pubTimestamp":1763236573,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，南微医学报收于83.85元，较上周的81.33元上涨3.1%。本周，南微医学11月12日盘中最高价报87.07元。南微医学当前最新总市值157.51亿元，在医疗器械板块市值排名19/126，在两市A股市值排名1219/5165。本周关注点来自交易信息汇总：11月11日及14日南微医学合计发生超7000万元大宗交易。来自公司公告汇总：南微医学2025年第三次临时股东大会审议通过取消监事会并修订公司章程的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2583715005","title":"11月14日南微医学现5806.94万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2583715005","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583715005?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:35","pubTimestamp":1763112929,"startTime":"0","endTime":"0","summary":"证券之星消息，11月14日南微医学发生大宗交易，交易数据如下：大宗交易成交价格82.18元，相对当日收盘价折价1.99%，成交70.66万股，成交金额5806.94万元，买方营业部为广发证券股份有限公司上海玉兰路证券营业部，卖方营业部为广发证券股份有限公司总部。近三个月该股共发生5笔大宗交易，合计成交1.01万手，折价成交1笔。截至2025年11月14日收盘，南微医学报收于83.85元，下跌1.93%，换手率0.59%，成交量1.11万手，成交额9354.95万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2582370561","title":"南微医学（688029）披露取消监事会并修订公司章程议案获通过，11月12日股价下跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582370561","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582370561?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:42","pubTimestamp":1762958538,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，南微医学报收于85.9元，较前一交易日下跌0.31%，最新总市值为161.36亿元。该股当日开盘86.17元，最高87.07元，最低85.21元，成交额达1.66亿元，换手率为1.03%。近日，南微医学科技股份有限公司发布2025年第三次临时股东大会决议公告，公司于2025年11月12日召开股东大会，审议通过了《关于取消监事会并修订<公司章程>的议案》及多项公司治理制度修订、新增和废止议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2582547133","title":"11月11日南微医学现1292.56万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2582547133","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582547133?lang=zh_cn&edition=full","pubTime":"2025-11-11 17:27","pubTimestamp":1762853246,"startTime":"0","endTime":"0","summary":"证券之星消息，11月11日南微医学发生大宗交易，交易数据如下：近三个月该股共发生4笔大宗交易，合计成交3000.0手。该股近期无解禁股上市。截至2025年11月11日收盘，南微医学(688029)报收于86.17元，上涨3.89%，换手率1.69%，成交量3.17万手，成交额2.69亿元。该股近半年内有股东持股变动，合计净减持6.2万股，股东增减持明细如下表：该股最近90天内共有13家机构给出评级，买入评级12家，增持评级1家；过去90天内机构目标均价为102.62。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100028327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2582864660","title":"每周股票复盘：南微医学（688029）拟取消监事会改由董事会审计委员会履职","url":"https://stock-news.laohu8.com/highlight/detail?id=2582864660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582864660?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:00","pubTimestamp":1762635643,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，南微医学报收于81.33元，较上周的82.88元下跌1.87%。本周关注点公司公告汇总：南微医学拟取消监事会，由董事会审计委员会行使监事会职权公司公告汇总：公司将修订《公司章程》及相关治理制度，新增《董事高管薪酬管理制度》公司公告汇总：相关议案已通过董事会及监事会审议，将提交股东大会审议公司公告汇总南微医学科技股份有限公司拟取消监事会，由董事会审计委员会行使监事会职权，并据此修订《公司章程》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2581605703","title":"南微医学（688029）披露拟取消监事会并修订多项治理制度，11月06日股价上涨0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581605703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581605703?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:26","pubTimestamp":1762421165,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，南微医学报收于82.45元，较前一交易日上涨0.83%，最新总市值为154.88亿元。该股当日开盘81.77元，最高82.95元，最低81.3元，成交额达1.29亿元，换手率为0.83%。根据近日发布的《南微医学科技股份有限公司2025年第三次临时股东大会会议资料》，公司拟取消监事会，由董事会审计委员会行使监事会职权，并据此修订《公司章程》。上述议案已分别经公司第四届董事会第十一次会议及第四届监事会第九次会议审议通过，现提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600027130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2579191536","title":"南微医学（688029）2025年三季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2579191536","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579191536?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:16","pubTimestamp":1761689801,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期南微医学发布2025年三季报。截至本报告期末，公司营业总收入23.81亿元，同比上升18.29%，归母净利润5.09亿元，同比上升12.9%。按单季度数据看，第三季度营业总收入8.15亿元，同比上升20.12%，第三季度归母净利润1.46亿元，同比上升3.74%。本报告期南微医学公司应收账款体量较大，当期应收账款占最新年报归母净利润比达97.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900008803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"gpt_icon":0},{"id":"2578936986","title":"南微医学(688029)9月30日股东户数1.25万户，较上期增加1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578936986","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578936986?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:23","pubTimestamp":1761643396,"startTime":"0","endTime":"0","summary":"证券之星消息，近日南微医学披露，截至2025年9月30日公司股东户数为1.25万户，较6月30日增加170.0户，增幅为1.38%。在医疗器械行业个股中，南微医学股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年6月30日至2025年9月30日，南微医学区间涨幅为49.32%，在此期间股东户数增加170.0户，增幅为1.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2578962848","title":"南微医学最新公告：前三季度净利润同比增长12.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578962848","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578962848?lang=zh_cn&edition=full","pubTime":"2025-10-27 23:00","pubTimestamp":1761577236,"startTime":"0","endTime":"0","summary":"南微医学(688029.SH)公告称，第三季度营收为8.15亿元，同比增长20.12%；净利润为1.46亿元，同比增长3.74%。前三季度营收为23.81亿元，同比增长18.29%；净利润为5.09亿元，同比增长12.90%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700037153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"gpt_icon":0},{"id":"2578502771","title":"每周股票复盘：南微医学（688029）完成3002万元股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2578502771","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578502771?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:29","pubTimestamp":1761420548,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，南微医学报收于88.33元，较上周的86.21元上涨2.46%。本周，南微医学10月24日盘中最高价报89.09元。10月23日盘中最低价报85.51元。南微医学当前最新总市值165.93亿元，在医疗器械板块市值排名16/126，在两市A股市值排名1134/5160。回购股份存放于专用证券账户，将用于员工持股计划或股权激励，并在三年内完成转让；若未转让完毕，将依法注销。回购期间，第一大股东中科招商减持62,000股，其他相关主体无买卖行为。本次回购不影响公司上市地位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2577354427","title":"南微医学（688029）披露股份回购实施结果，10月22日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577354427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577354427?lang=zh_cn&edition=full","pubTime":"2025-10-22 17:17","pubTimestamp":1761124641,"startTime":"0","endTime":"0","summary":"截至2025年10月22日收盘，南微医学报收于86.74元，较前一交易日下跌0.81%，最新总市值为162.94亿元。公告显示，南微医学科技股份有限公司于2025年4月22日披露股份回购方案，回购期限为2025年4月22日至10月21日，拟回购金额3,000万元至5,000万元，回购价格上限95.04元/股，用于员工持股计划或股权激励。回购股份存放于公司回购专用证券账户，未来将用于员工持股计划或股权激励，并在三年内完成转让。本次回购不影响公司上市地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200027252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"1158775960","title":"Sapura Industrial表示子公司与Funa Micro Technology Pte签署合资协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1158775960","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158775960?lang=zh_cn&edition=full","pubTime":"2025-10-14 22:28","pubTimestamp":1760452108,"startTime":"0","endTime":"0","summary":"Sapura Industrial Bhd宣布，其子公司与Funa Micro Technology Pte签署合资企业协议。\n该合资企业将在马来西亚建立锂电池精密结构件制造设施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2574576024","title":"每周股票复盘：南微医学（688029）回购进展披露，已支付约960万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574576024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574576024?lang=zh_cn&edition=full","pubTime":"2025-10-12 01:45","pubTimestamp":1760204714,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，南微医学报收于97.78元，较上周的100.35元下跌2.56%。本周，南微医学10月9日盘中最高价报100.94元。南微医学当前最新总市值183.68亿元，在医疗器械板块市值排名12/126，在两市A股市值排名1038/5158。公司公告汇总南微医学科技股份有限公司于2025年4月22日披露股份回购方案，回购期限为2025年4月22日至10月21日，拟回购金额为3,000万元至5,000万元，用途为员工持股计划或股权激励。2025年9月公司未实施回购。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2574697508","title":"股市必读：9月30日南微医学发生2笔大宗交易 成交金额1505.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574697508","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574697508?lang=zh_cn&edition=full","pubTime":"2025-10-09 01:40","pubTimestamp":1759945219,"startTime":"0","endTime":"0","summary":"截至2025年9月30日收盘，南微医学报收于100.35元，上涨7.52%，换手率2.24%，成交量4.21万手，成交额4.14亿元。来自公司公告汇总：因实施2025年半年度权益分派，南微医学回购价格上限由95.54元/股调整至95.04元/股，自9月26日起生效。交易信息汇总资金流向9月30日主力资金净流入2454.65万元，占总成交额5.93%；游资资金净流入346.88万元，占总成交额0.84%；散户资金净流出2801.53万元，占总成交额6.76%。大宗交易9月30日南微医学发生2笔大宗交易，成交金额1505.26万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900000512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2571314072","title":"南微医学涨7.52%，国金证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2571314072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571314072?lang=zh_cn&edition=full","pubTime":"2025-09-30 16:21","pubTimestamp":1759220512,"startTime":"0","endTime":"0","summary":"今日南微医学涨7.52%，收盘报100.35元。2025年8月12日，国金证券研究员甘坛焕,何冠洲发布了对南微医学的研报《推进国际化战略，中报海外持续高增长》，该研报对南微医学给出“买入”评级。研报中预计2025-2027年公司归母净利润分别为6.75、8.25、10.12亿元，同比+22%、+22%、+23%，现价对应PE为26、21、17倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中金公司的冯喜鹏。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000025885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"gpt_icon":0},{"id":"2571337577","title":"南微医学（688029）披露2025年半年度权益分派实施后调整回购价格上限，9月29日股价下跌0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571337577","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571337577?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:35","pubTimestamp":1759156523,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘，南微医学报收于93.33元，较前一交易日下跌0.99%，最新总市值为175.32亿元。近日，南微医学科技股份有限公司发布关于2025年半年度权益分派实施后调整回购价格上限的公告。根据公告内容，因实施2025年半年度权益分派，向全体股东每10股派发现金红利5.00元（含税），公司对回购股份的价格上限进行相应调整。公司表示，除上述调整外，本次回购股份方案的其他事项均不发生变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900035590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2570826891","title":"每周股票复盘：XD南微医（688029）南微医学拟每股派0.5元现金红利","url":"https://stock-news.laohu8.com/highlight/detail?id=2570826891","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570826891?lang=zh_cn&edition=full","pubTime":"2025-09-28 02:39","pubTimestamp":1758998351,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，XD南微医报收于94.26元，较上周的91.27元上涨3.28%。本周，XD南微医9月25日盘中最高价报98.8元。本周关注点公司公告汇总：南微医学2025年半年度权益分派方案确定，每10股派发现金红利5.00元（含税）。截至公告日，公司总股本187,847,422股，扣除回购股份1,016,119股，实际参与分配股本186,831,303股，合计派发现金红利93,415,651.50元（含税）。差异化分红导致每股现金红利按总股本摊薄后约为0.4973元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800000625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2569920072","title":"南微医学（688029）披露2025年半年度权益分派实施公告，9月22日股价上涨0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569920072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569920072?lang=zh_cn&edition=full","pubTime":"2025-09-22 17:21","pubTimestamp":1758532914,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘，南微医学报收于91.61元，较前一交易日上涨0.37%，最新总市值为172.09亿元。公司于近日发布《2025年半年度权益分派实施公告》。股权登记日为2025年9月25日，除权（息）日及现金红利发放日均为2025年9月26日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200022899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2565528637","title":"中国银河：给予南微医学买入评级，目标价134.67元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565528637","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565528637?lang=zh_cn&edition=full","pubTime":"2025-09-07 17:45","pubTimestamp":1757238325,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对南微医学进行研究并发布了研究报告《南微医学深度报告：内镜耗材龙头全球化提速，创新驱动二次成长》，给予南微医学买入评级，目标价134.67元。南微医学是技术实力过硬、产品系列丰富的国产微创器械领军企业，聚焦微创诊疗全链条，打造精准介入解决方案。微创器械代际跃迁之际，以南微医学为代表的国产品牌实现弯道超车，形成差异化竞争优势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700009040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","601881"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765800126234,"stockEarnings":[{"period":"1week","weight":-0.0201},{"period":"1month","weight":-0.0922},{"period":"3month","weight":-0.1519},{"period":"6month","weight":0.1832},{"period":"1year","weight":0.0965},{"period":"ytd","weight":0.1776}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南微医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"12515人(较上一季度增加1.38%)","perCapita":"15009股","listingDate":"2019-07-22","address":"江苏省南京市浦口区高新开发区高科三路10号","registeredCapital":"18784万元","survey":" 南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜诊疗器械、微波/射频消融设备及耗材、一次性内镜。","listedPrice":52.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南微医学,688029,南微医学股票,南微医学股票老虎,南微医学股票老虎国际,南微医学行情,南微医学股票行情,南微医学股价,南微医学股市,南微医学股票价格,南微医学股票交易,南微医学股票购买,南微医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}